$103.96 1.78 (1.74%)
19:54 EST ABBV Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 164.97B
PE Ratio 26.12
Volume (Avg. Vol.) 9.33M
Day's Range 102.58 - 104.82
52-Week Range 62.55 - 104.82
Dividend & Yield 3.59 (3.45%)
ABBV Stock Predictions, Articles, and AbbVie News
- From InvestorPlace
- From the Web
Investors have burned of late chasing high-yield dividend stocks. These 4 stocks with yields more than 5% should buck that trend.
Blue-chip stocks can generate large returns over time, making for great investments in a turbulent economy. Here are my top 7 picks.
Investing in biotech stocks may feel daunting to many investors, but these three stocks deserve to be on your watchlist.
AbbVie (ABBV) news for Friday includes results from the biopharmaceutical company's earnings report for the third quarter of 2020.
Biotech stocks are always going to be here, in good times and bad. Let's look at a few that are worth considering on the long side.
If you’re looking to generate income, here are 7 dividend stocks to buy that will deliver generous total returns over the long haul.
Times have been tough lately for income investors, but these high-yield stocks whose dividends are safe remain worth a second look.
Chasing high yields alone will ruin an income investor’s returns, so we look at these picks that offer a balance of stability and dividend income growth.
By Alex Sirois
Juicy dividends or explosive growth stocks? Most investors don't want to choose. Here are 6 dividend stocks to keep both sides happy.
Investors can still own AbbVie stock at a good price, even in the wake of a potentially lifesaving collaboration.
With a 20-year timeline, you have multiple choices for dividend stocks to buy. Here are 30 names that should do very well.
By Alex Sirois
You can find the best marijuana stocks to buy by considering their revenue rather than chasing pure hype. Here are six that fit the bill.
Hot stocks are easy to find, but if you wait too long to buy them, you will have big regrets. Buy these seven stocks before it's too late.
AbbVie earnings on Friday have ABBV stock slighty lower despite the company beating EPS and revenue estimates from Wall Street.
As the market continues to deal with the pandemic, these five cheap drug stocks have solid dividend yields of 4% and almost 37% upside.
Fortunately, with these strong blue-chip stocks, buying safety doesn’t mean you’re going to miss out on growth. Here's why.
There’s a select group of pharmaceutical stocks that stand to win without even looking for a Covid-19 cure.
The pharmaceutical market has its ups and downs, but that doesn't mean every investment is risky as ABBV stock is a reasonably safe bet.
From Talk Markets
The Daily Biotech Pulse: Alnylam's Oxluma Snags Early FDA Approval, DBV Chief Scientific Officer To Depart, Decision Day For Liquidia
From The Motley Fool
Navellier RatingsPowered by Portfolio Grader